News

Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.
Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...
Experts have shared their thoughts on the impacts that GLP-1 medications such as Ozempic can have on libido as a side effect ...
Historically, managing type 2 diabetes in advanced chronic kidney disease (CKD) has been challenging due to a lack of therapies and increased risks for adverse events.
GLP-1 RAs are associated with a modestly increased risk for GERD and gallstone disease but not with GI and biliary complications.
Here’s a roundup of numbers from the last week of HR news — including the percentage of managers who use AI to help determine ...
A study published in the Journal of Medical Toxicology by researchers at the University of Alabama at Birmingham found that ...
The expert has revealed why the GLP-1 medication could be playing a role in the bedroom and paving the way for divorce in ...
Glucagon-like peptide-1 receptor agonists (GLP-1RA) drugs, such as Ozempic and Wegovy, are often referred to as "miracle ...
A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...